RegulatoryOfficial

Fimea issues guidance on company mandates ahead of non-prescription medicine retail licence applications

🇫🇮 Fimea · Thu 05 Nov 2026

Finland's medicines agency has set out how mandates for acting on behalf of a company should be prepared, so retail licence applications come from properly authorised representatives.

Fimea, the Finnish Medicines Agency, has published instructions on how mandates for acting on behalf of a company should be set up. The guidance is meant to help businesses prepare to apply for a retail licence for non-prescription medicines.

According to the agency's summary, companies planning to sell non-prescription medicines at retail need to follow the instructions. The aim is to ensure that licence applications are submitted by representatives who have been properly authorised to act for the company.

The full text of the instructions was not available for this report, so details such as the required format of a mandate, who may grant one, supporting documents, or the application timetable are not covered here. Companies should consult Fimea's published guidance directly for those requirements.

What it means for your team

  • Retailers planning to sell non-prescription medicines in Finland should review Fimea's mandate instructions before preparing a licence application.
  • Regulatory and legal teams should confirm who is authorised to act for the company and that the authority is documented in line with the guidance.
  • Errors in representation could affect how an application is handled, so checking mandate arrangements early is prudent.
  • Details of requirements and timelines should be taken from Fimea's original publication.

Official source: Fimea ↗

Article written by VigiEye from the official source (Fimea). AI-assisted; check the source before acting.

More Regulatory All →